Clinical Trial Update: GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases [Phase 1]

View source ↗

Summary

Phase 1 study of GDC-0084 with radiation therapy in patients with PIK3CA-mutated solid tumor brain metastases or leptomeningeal metastases; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Leptomeningeal Metastasis

Drugs mentioned

• GDC-0084

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Metastases, Leptomeningeal Metastasis | Phase 1 | Status: ACTIVE_NOT_RECRUITING